
Melanocytes exhibit a complex and intriguing relationship with the skin immune response, leading to several clinical conditions. In some disorders, inappropriate melanocyte destruction (e.g. vitiligo, halo naevi) is problematic, while in others, immune tolerance should be broken (melanoma). Essential parts of the dysregulated pathways have been unravelled in pigment disorders, ranging from upregulated interferon (IFN)‐γ signalling to memory T cells, regulatory T cells, and immune checkpoints. Although many factors are involved, targeting key players such as IFN‐γ or checkpoint inhibitors (e.g. programmed death‐ligand 1 (PD‐L1)] can shift the balance and lead to impressive outcomes. In this review, the study focuses on the immunological mechanisms of the most common inflammatory disorders where the immune system's interaction with melanocytes plays a crucial role. This can provide new insights into the current state of melanocyte research.
Like
Save
Share